QTRX
Quanterix Corporation
Medical Devices · Healthcare · United States
2.91
close · 2026-10-30
value
20
cheaper than peers20
quality
56
stronger fundamentals56
ranked against
Medical Devices
value
quality
84 peerswide variation
Value inputs
| measure | company | vs peers |
| price to book | 0.58× | 94 |
| price to sales | 0.90× | 84 |
| earnings yield, 2 years ago | -25.8% | 34 |
| earnings yield, 1 year ago | -34.4% | 31 |
| cash flow yield, 2 years ago | -16.5% | 31 |
| cash flow yield, 1 year ago | -28.0% | 19 |
| cash flow yield, 3 years ago | -43.8% | 15 |
| earnings yield, 3 years ago | -89.8% | 14 |
| cash flow yield, latest year | -58.1% | 11 |
| earnings yield, latest year | -86.4% | 10 |
10 of 12 measures available
Quality inputs
| measure | company | vs peers |
| revenue growth | 34.4% | 92 |
| debt to equity | 14.1% | 71 |
| return on equity | -46.5% | 32 |
| operating margin | -68.4% | 19 |
4 of 4 measures available
Facts
| market cap | $137M |
| free cash flow | -$29.9M |
| employees | 450 |
| first trade | 2017-12-07 |
| next earnings | 2026-11-09 |
| fundamentals updated | 2026-08-28 |
Annual history
| measure | 2025 | 2024 | 2023 | 2022 |
| diluted eps | -2.51 | -1.00 | -0.75 | -2.61 |
| free cash flow | -$79.8M | -$38.5M | -$22.7M | -$60.2M |
| net income | -$107.2M | -$38.5M | -$28.4M | -$99.6M |
| revenue | $138.7M | $135.4M | $121.1M | $105.0M |
| unusual items | -$11.2M | $0 | -$1.3M | -$29.6M |